The Safety, Tolerability and Immunogenicity of COVID-19 Vaccine (SCTV01C) in Healthy, Unvaccinated Adults

NCT05148091 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

478

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: SCTV01C
OTHER: Adjuvant
OTHER: Saline

Sponsor

Sinocelltech Ltd.